← Leaderboards
Cherry P Wongtrakool
Emory University
$1,454,098
Attributed
$2,279,528
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $443.8K · FY2005–25$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,279,528 · 2
VA$0 · 2
By mechanism
R01$1,650,860 · 1
K08$628,668 · 1
I01$0 · 1
IK2$0 · 1
Top collaborators
- Khalid S. Salaita6 shared
Most similar at Emory University
Same institution · by research overlap
- Khalid S. Salaita$12,706,564
- C Michael Hart$6,695,798
- Nusaiba Baker$141,333
- Sherry Adesina$61,144
Others in their field
Top investigators on “Lung”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$372,040,227
- Chanza Baytop · Westat, Inc.$271,217,917
- Richard K. Wilson · Washington University$201,818,043
- Walter John Curran · Thomas Jefferson University$112,093,071
Research focus
LungIn VitroMediatingAirway HyperresponsivenessMethacholineDesignAffectChronicPeptidesLung DiseasesInflammationCleaved CellCellsResponseMouse ModelSmall Interfering RnaCharacteristicsAsthmaGenetic TranscriptionPhenotypeInnovationCoupledMorbidity - Disease RateTranscription Factor
Grant awards (15)
Mitophagy in pulmonary hypertension: Novel roles of PTEN-Induced Kinase-1 in the pathobiology of pulmonary artery smooth muscle cell proliferation and mitochondrial dysfunction$0
I01 · FY2025 · VA · contact PI
Catalytic Nanotherapies to Treat Lung Disease$381,816
R01 · FY2021 · HL
Catalytic Nanotherapies to Treat Lung Disease$62,023
R01 · FY2021 · HL
Catalytic Nanotherapies to Treat Lung Disease$382,560
R01 · FY2020 · HL
Catalytic Nanotherapies to Treat Lung Disease$57,374
R01 · FY2020 · HL
Catalytic Nanotherapies to Treat Lung Disease$383,236
R01 · FY2019 · HL
Catalytic Nanotherapies to Treat Lung Disease$383,851
R01 · FY2018 · HL
Induction of Nerve Growth Factor by Nicotine Leads to Airway Dysfunction$0
IK2 · FY2014 · VA · contact PI
Induction of Nerve Growth Factor by Nicotine Leads to Airway Dysfunction$0
IK2 · FY2013 · VA · contact PI
Induction of Nerve Growth Factor by Nicotine Leads to Airway Dysfunction$0
IK2 · FY2012 · VA · contact PI
Prenatal nicotine lung development & airway dysfunction$126,036
K08 · FY2009 · HL · contact PI
Prenatal nicotine lung development & airway dysfunction$126,036
K08 · FY2008 · HL · contact PI
Prenatal nicotine lung development & airway dysfunction$126,036
K08 · FY2007 · HL · contact PI
Prenatal nicotine lung development & airway dysfunction$124,524
K08 · FY2006 · HL · contact PI
Prenatal nicotine lung development &airway dysfunction$126,036
K08 · FY2005 · HL